These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28232176)

  • 1. Patterns of Pelvic Lymph Node Dissection at the Time of Radical Prostatectomy for Low-risk Men.
    Chalfin HJ; Feng Z; Trock BJ; Partin AW
    Urology; 2017 Jun; 104():143-149. PubMed ID: 28232176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes.
    Mazzone E; Preisser F; Nazzani S; Tian Z; Bandini M; Gandaglia G; Fossati N; Montorsi F; Graefen M; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    Eur Urol Oncol; 2019 Sep; 2(5):541-548. PubMed ID: 31411992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Racial disparities in lymph node dissection at radical prostatectomy: A Surveillance, Epidemiology and End Results database analysis.
    Preisser F; Nazzani S; Bandini M; Marchioni M; Tian Z; Saad F; Chun FK; Shariat SF; Montorsi F; Huland H; Graefen M; Tilki D; Karakiewicz PI
    Int J Urol; 2018 Nov; 25(11):929-936. PubMed ID: 30146729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head-to-head comparison of lymph node density and number of positive lymph nodes in stratifying the outcome of patients with lymph node-positive prostate cancer submitted to radical prostatectomy and extended lymph node dissection.
    Passoni NM; Abdollah F; Suardi N; Gallina A; Bianchi M; Tutolo M; Fossati N; Gandaglia G; Salonia A; Freschi M; Rigatti P; Montorsi F; Briganti A
    Urol Oncol; 2014 Jan; 32(1):29.e21-8. PubMed ID: 23490908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Extended Pelvic Lymph Node Dissection on Oncologic Outcomes in Patients with D'Amico Intermediate and High Risk Prostate Cancer Treated with Radical Prostatectomy: A Multi-Institutional Study.
    Preisser F; van den Bergh RCN; Gandaglia G; Ost P; Surcel CI; Sooriakumaran P; Montorsi F; Graefen M; van der Poel H; de la Taille A; Briganti A; Salomon L; Ploussard G; Tilki D;
    J Urol; 2020 Feb; 203(2):338-343. PubMed ID: 31437119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization and impact of surgical technique on the performance of pelvic lymph node dissection at radical prostatectomy: Results from the Shared Equal Access Regional Cancer Hospital database.
    McGinley KF; Sun X; Howard LE; Aronson WJ; Terris MK; Kane CJ; Amling CL; Cooperberg MR; Freedland SJ
    Int J Urol; 2016 Mar; 23(3):241-6. PubMed ID: 26667212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation in pelvic lymph node dissection among patients undergoing radical prostatectomy by hospital characteristics and surgical approach: results from the National Cancer Database.
    Wang EH; Yu JB; Gross CP; Smaldone MC; Shah ND; Trinh QD; Nguyen PL; Sun M; Han LC; Kim SP
    J Urol; 2015 Mar; 193(3):820-5. PubMed ID: 25242393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes of salvage lymph node dissection for clinically recurrent prostate cancer: results of a single-institution series with a minimum follow-up of 5 years.
    Suardi N; Gandaglia G; Gallina A; Di Trapani E; Scattoni V; Vizziello D; Cucchiara V; Bertini R; Colombo R; Picchio M; Giovacchini G; Montorsi F; Briganti A
    Eur Urol; 2015 Feb; 67(2):299-309. PubMed ID: 24571959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification.
    Leyh-Bannurah SR; Budäus L; Zaffuto E; Pompe RS; Bandini M; Briganti A; Montorsi F; Schiffmann J; Shariat SF; Fisch M; Chun F; Huland H; Graefen M; Karakiewicz PI
    Urol Oncol; 2018 Feb; 36(2):81.e17-81.e24. PubMed ID: 29248430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Extent of lymph node dissection improves survival in prostate cancer patients treated with radical prostatectomy without lymph node invasion.
    Preisser F; Bandini M; Marchioni M; Nazzani S; Tian Z; Pompe RS; Fossati N; Briganti A; Saad F; Shariat SF; Heinzer H; Huland H; Graefen M; Tilki D; Karakiewicz PI
    Prostate; 2018 May; 78(6):469-475. PubMed ID: 29460290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extent of pelvic lymph node dissection and the impact of standard template dissection on nomogram prediction of lymph node involvement.
    Godoy G; Chong KT; Cronin A; Vickers A; Laudone V; Touijer K; Guillonneau B; Eastham JA; Scardino PT; Coleman JA
    Eur Urol; 2011 Aug; 60(2):195-201. PubMed ID: 21257258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extent of pelvic lymph node dissection improves early oncological outcomes for patients with high-risk prostate cancer without lymph node involvement after robot-assisted radical prostatectomy.
    Morizane S; Honda M; Shimizu R; Tsounapi P; Teraoka S; Yumioka T; Yamaguchi N; Kawamoto B; Iwamoto H; Hikita K; Takenaka A
    Int J Clin Oncol; 2022 Apr; 27(4):781-789. PubMed ID: 35076818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial/ethnic differences in receipt of pelvic lymph node dissection among men with localized/regional prostate cancer.
    Hayn MH; Orom H; Shavers VL; Sanda MG; Glasgow M; Mohler JL; Underwood W
    Cancer; 2011 Oct; 117(20):4651-8. PubMed ID: 21456009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of patients with lymph node metastasis treated with radical prostatectomy without adjuvant androgen-deprivation therapy.
    Touijer KA; Mazzola CR; Sjoberg DD; Scardino PT; Eastham JA
    Eur Urol; 2014 Jan; 65(1):20-5. PubMed ID: 23619390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer.
    Yuh BE; Ruel NH; Mejia R; Novara G; Wilson TG
    BJU Int; 2013 Jul; 112(1):81-8. PubMed ID: 23351148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pelvic lymph node dissection in robot-assisted laparoscopic radical prostatectomy: safety and adequacy in introductory series].
    Sunada T; Kobayashi T; Shibasaki N; Okada Y; Negoro H; Terada N; Yamasaki T; Matsui Y; Inoue T; Kamba T; Ogawa O
    Hinyokika Kiyo; 2015 Mar; 61(3):89-93. PubMed ID: 25918265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The factors that affect the prediction of lymph node metastasis in prostate cancer.
    Turk H; Ün S; Koca O; Cinkaya A; Kodaz H; Zorlu F
    J Cancer Res Ther; 2018; 14(5):1094-1098. PubMed ID: 30197355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic/retroperitoneal salvage lymph node dissection for patients treated with radical prostatectomy with biochemical recurrence and nodal recurrence detected by [11C]choline positron emission tomography/computed tomography.
    Rigatti P; Suardi N; Briganti A; Da Pozzo LF; Tutolo M; Villa L; Gallina A; Capitanio U; Abdollah F; Scattoni V; Colombo R; Freschi M; Picchio M; Messa C; Guazzoni G; Montorsi F
    Eur Urol; 2011 Nov; 60(5):935-43. PubMed ID: 21840116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence Guided Targeted Pelvic Lymph Node Dissection for Intermediate and High Risk Prostate Cancer.
    Hruby S; Englberger C; Lusuardi L; Schätz T; Kunit T; Abdel-Aal AM; Hager M; Janetschek G
    J Urol; 2015 Aug; 194(2):357-63. PubMed ID: 25896557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hospital readmissions after limited vs. extended lymph node dissection during open and robot-assisted radical prostatectomy.
    Tyritzis SI; Wilderäng U; Lantz ΑW; Steineck G; Hugosson J; Bjartell A; Stranne J; Haglind E; Wiklund NP
    Urol Oncol; 2020 Jan; 38(1):5.e1-5.e8. PubMed ID: 31445896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.